February 16, 2021, Vol 325, No. 7, Pages 605-702
Race and Pharmacogenomics—Personalized Medicine or Misguided Practice?
Christopher W. Goodman, MD; Allan S. Brett, MD
JAMA. 2021;325(7):625-626. doi:10.1001/jama.2020.25473
This Viewpoint uses examples of recommendations for race-based pharmacogenetic testing to discuss flaws and inconsistencies with race and ethnicity as surrogates for biology, and the consequences of those deficiencies for clinical decision-making.